We are live on
!
Find out more
LA
Lau Associates Portfolio holdings
AUM
$201M
1-Year Est. Return
26.29%
This Fund
S&P 500
This Quarter
Est. Return
+9.37%
1 Year Est. Return
+26.29%
3 Year Est. Return
+44.49%
5 Year Est. Return
+59.98%
10 Year Est. Return
–
AUM
$201M
AUM Growth
+$11.8M
(+6.3%)
Cap. Flow
+$1.1M
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
53.57%
Holding
99
New
3
Increased
6
Reduced
35
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$2.88M |
| 2 |
Novartis
NVS
|
+$561K |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$467K |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$219K |
| 5 |
Walt Disney
DIS
|
+$200K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corteva
CTVA
|
+$643K |
| 2 |
TJX Companies
TJX
|
+$488K |
| 3 |
AbbVie
ABBV
|
+$473K |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
+$471K |
| 5 |
CGC
Canopy Growth
CGC
|
+$318K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.92% |
| 2 | Healthcare | 11.95% |
| 3 | Consumer Staples | 8.61% |
| 4 | Energy | 8.58% |
| 5 | Financials | 5.88% |
Similar funds
JFM
SHA
AC
AEPI
TWM
QCM
IAM
VC
Lau Associates's Q4 2019 Portfolio in Review
As of Q4 2019, Lau Associates held 99 positions worth $201M, up 6.3% from $189M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Lau Associates's Q4 2019 filing shows 3 new, 6 increased, 35 reduced and 5 closed positions. Its largest new stake was Vanguard FTSE Developed Markets ETF: 5,140 shares worth $226K. The largest sale was Corteva, an estimated $643K.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.
- Lau Associates's largest Q4 2019 buy was Vanguard FTSE Developed Markets ETF: 5,140 shares worth $226K.
- Lau Associates added most to JPMorgan Ultra-Short Income ETF in Q4 2019, an estimated $2.88M increase.
- Lau Associates's biggest Q4 2019 reduction was Corteva, cutting an estimated $643K.
- Lau Associates fully exited AbbVie in Q4 2019, selling an estimated $473K.
- Lau Associates's ten largest holdings make up 54% of its $201M portfolio in Q4 2019.
- Lau Associates opened 3 new positions and closed 5 in Q4 2019.
- Lau Associates's portfolio value rose 6.3% quarter-over-quarter to $201M.
Based on Lau Associates's 13F filing for Q4 2019, filed 5 Feb 2020.